Velmanase alfa-tycv: first FDA approval for non-CNS indications of alpha-mannosidosis

Published Date: 18 Feb 2023

Velmanase alfa-tycv: first FDA approval for non-CNS indications of alpha-mannosidosis

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

According to research, hospitals can save money and help cancer patients by implementing a basic intervention.

2.

Chronic stress and obesity work together to accelerate pancreatic cancer development and growth, study finds

3.

A Lot Can Be Said About You by Including Yourself in Photos.

4.

Watch for Psoriasis After Cancer Immunotherapy, Study Says

5.

Coupling dye and fiducial marking can improve precision in pulmonary nodule surgical resection


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot